DERMATOLOGÍA PERUANA - VOL. 10, Nº 2, JULIO  -  DICIEMBRE  2000


REFERENCIAS BIBLIOGRÁFICAS

1. González G, Sánchez P, Avila H, y col. Manual de Estrategias para la búsqueda de Información: Medicina Basada en Evidencias. 1ª edición, 1998

2. Bravo R. Medicina Basada en la Evidencia http://www.infodoctor.org/rafabravo/mbe.htm

3. Bigby M. Welcome to the Evidence-Based Dermatology. Arch Dermatol 1999 (135):1512.

4. Abeni D, Bigby M, Pasquini P, y col. Evidence-Based Dermatology Arch Dermatol 2000 (136):1552

5. Abeni D, Bigby M, Pasquini P, y col. Evidence-Based Dermatology Arch Dermatol 2000 (136):1148

6. Cochrane AL. Effectiveness and Efficiency. Random Reflections on Health Services. London: Nuffield Provincial Hospitals Trust, 1972. (Reimpreso en 1989 en asociación con el BMJ)

7. Bigby M. Welcome to Evidence-Based Medicine. Arch Dermatol 1998 134: 1516-7.

8. Polit D, Hungler B. Investigación en Ciencias de la Salud 1994, 4. Edición, Editorial Interamericana SA, México

9. Adetugbo K, Williams H. How Well Are Randomized Controlled Trials Reported in the Dermatology Literature? Arch Dermatol 2000; 136: 381.

10. Smith R. What clinical information do doctors need? BMJ 1996; 313: 1062-8.

11. Guyatt G, Cairs J, Churchill D, y col. Evidence-Based Medicine A new Approach to Teaching the Practice of Medicine. JAMA 1992; 17: 2420-5.

12. Straus S, Sackett D. Bringing Evidence to the Clinic. Arch Dermatol 1998; 34: 1319-0.

13. Mulrow CD, Oxman AD (eds). The Cochrane Handbook [updated september]. En: The Cochrane Library [database on disk and CDROOM]. The Cochrane Collaboration, Oxford: Update Software 1994

14. Bias. Bandolier 2000 Oct: 80-2 http://www.jr2.ox.ac.uk/Bandolier/band80/b80.html.

15. Evidence Based Drug Therapy. What do the Numbers Mean? Therapeutics Letter 15 agosto-octubre 1996 University of British Columbia Vancouver, Canada http://www.ti.ubc.ca/pages/letter15.html.

16. Davies HT. Interpreting measures of treatment effect Hosp Med 1998 59(6):499-501.

17. de Craen AJ, Vickers AJ, Tijssen JG, Kleijnen J. Number-needed-to-treat and placebo-controlled trials. Lancet 1998; 351: 310.

18. Green L Using evidence-based medicine in clinical practice. Prim Care 1998 Jun;25(2):391-400

19. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997; 126:712-20.

20. Sackett DL. On some clinically useful measures of the effects of treatment Evidence-Based Medicine 1996;1:37-8.

21. North D Number needed to treat. Absolute risk reduction may be easier for patients to understand BMJ 1995 May 13;310(6989):1269

22. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310: 452-4.

23. Cáceres H, Rueda, M, Ballona R, y col. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis, J Am Acad Dermatol 2000; 42: 80-4.

24. Rees J. Evidence-based medicine:The epistemology that isn’t. J Am Acad Dermatol 2000; 43: 727-9.

25. Falcao M. Evidence-based Medicine. Rev Hosp Clin Fac Med S Paulo 2000; 55:111-2.

REGRESAR AL ARTÍCULO


Regresar